Quercetin for Endurance

Verdict: Does not meaningfully improve endurance

Quercetin does not provide a practically meaningful boost to endurance or aerobic capacity. High-quality evidence shows any effect is statistically detectable but trivial in size, and authoritative bodies do not recommend it as a performance aid.

D 🔴 D Counter-Evidence Counter-Evidence

🔬Why this grade7-layer evidence engine

This claim is graded D (Counter-Evidence) because the strongest evidence converges against a useful effect. Two high-quality meta-analyses found only a trivial benefit: one reported an effect size of 0.15 (about a 2% gain; PMID 21606866), and the other found VO2max up just 1.94% and endurance performance up 0.74%, concluding quercetin is unlikely to be ergogenic (PMID 22805526).

The positive headline results come from small, low-quality trials in untrained people (n=12 each; PMID 20190352, PMID 35571883) and do not replicate in trained athletes. A 6-week double-blind RCT in endurance runners found no improvement in VO2peak, running economy, or 10 km time, despite reduced lipid peroxidation (PMID 24379709), and a 2023 systematic review reported varied findings with no ergogenic consensus (PMID 38288402).

Regulators and clinics reinforce this. The FDA addresses only food-additive safety (GRAS), not performance; EFSA rejected all of quercetin's health claims; and WHO/IARC list it only as Group 3 for carcinogenicity. NIH ODS and major clinics offer no endorsement for endurance, so quercetin should be viewed as a supplement that does not work for this purpose.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.30
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
D · Counter-Evidence
Confidence
83%
Highly consistent evidence
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.20
L3 MechanismPlausibility
0.25
L11 AI re-checkIndependent read
0.30
L5 Clinical bodiesAuthoritative stance
0.40
L1 ExamineGlobal benchmark
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.302
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (3 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (6)L2 · primary research & systematic reviews

Quercetin and endurance exercise capacity: a systematic review and meta-analysis
PMID: 21606866 2011 統合分析 n = 254
Finding: Statistically significant but trivial-to-small effect favoring quercetin (ES = 0.15, p = 0.021), equating to ~2% improvement over placebo.
🟢 High quality Effect size: ES = 0.15 (trivial-to-small)
View on PubMed
Effects of quercetin supplementation on endurance performance and maximal oxygen consumption: a meta-analysis
PMID: 22805526 2013 統合分析 n = 288
Finding: VO2max increased 1.94% (p = .02); endurance performance +0.74% (p = .02). Magnitude-based inference: effect likely trivial for both trained and untrained. Quercetin unlikely to be ergogenic.
🟢 High quality Effect size: VO2max +1.94% (95% CI 0.30–3.59); EP +0.74% (95% CI 0.10–1.39)
View on PubMed
Long-term quercetin supplementation reduces lipid peroxidation but does not improve performance in endurance runners
PMID: 24379709 2013 RCT (double-blind)
Finding: Quercetin reduced serum MDA (p = 0.019) but showed no significant improvement in VO2peak, running economy, heart rate, or 10 km performance.
Government Effect size: null
View on PubMed
The dietary flavonoid quercetin increases VO(2max) and endurance capacity
PMID: 20190352 2010 RCT (double-blind) n = 12
Finding: VO2max increased 3.9% vs placebo (p < .05); ride time to fatigue increased 13.2% (p < .05) in untrained participants.
🟠 Limited quality Academic Effect size: VO2max +3.9%; TTE +13.2%
View on PubMed
Short-Term Oral Quercetin Supplementation Improves Post-exercise Insulin Sensitivity, Antioxidant Capacity and Enhances Subsequent Cycling Time to Exhaustion in Health
PMID: 35571883 2022 RCT (open-label) n = 12
Finding: 7-day quercetin significantly improved time to exhaustion and antioxidant capacity (p < 0.05); post-exercise IL-6 and CK attenuated. Pilot study, small n.
🟠 Limited quality Academic Effect size: null
View on PubMed
Quercetin in Sports and Exercise: A review
PMID: 38288402 2023 系統性回顧
Finding: Varied findings; VO2max improvement in 2 of 34 studies, TTE in 4 studies. Training status, quercetin source, and exercise protocol moderate efficacy. No clear ergogenic consensus.
Effect size: null
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Cautious
FDA has no questions; some uses may require a color additive listing source↗
L4b EU EFSA
Against
L4d TW TFDA / 衛福部
Neutral
洋蔥萃取物原料係由洋蔥(Allium cepa)之鱗莖,經萃取製得。前點製得之洋蔥萃取物原料,其每日食用限量,以槲皮素(quercetin)計為1000毫克。 source↗
L5a NIH Office of Dietary Supplements
Cautious
L5e Specialty Society (condition-mapped)
Cautious
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬6 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-endurance-INT-quercetin-001 繁體中文版 →